Header Logo

Connection

Alan Keller to Doxorubicin

Back to Details
This is a "connection" page, showing publications Alan Keller has written about Doxorubicin.
Alan Keller
Connection Strength
0.226
Doxorubicin
  1. Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer. J Clin Oncol. 2004 Oct 01; 22(19):3893-901.
    View in: PubMed
    Score: 0.226
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.